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ABSTRACT 
Cognitive abilities vary among people. About 40-50% of this variability is due to general 
intelligence (g), which reflects the positive correlation among individuals’ scores on diverse 
cognitive ability tests. g is positively correlated with many life outcomes, such as education, 
occupational status, and health, motivating the investigation of its underlying biology. In 
psychometric research, a distinction is made between general fluid intelligence (gF) - the 
ability to reason in novel situations - and general crystallized intelligence (gC) - the ability to 
apply acquired knowledge. This distinction is supported by developmental and cognitive 
neuroscience studies. Classical epidemiological studies and recent genome-wide association 
studies (GWASs) have established that these cognitive traits have a large genetic component. 
However, no robust genetic associations have been published thus far due largely to the 
known polygenic nature of these traits and insufficient sample sizes. Here, using two GWAS 
datasets, in which the polygenicity of gF and gC traits was previously confirmed, a gene- and 
pathway-based approach was undertaken with the aim of characterizing and differentiating 
their genetic architecture. Pathway analysis, using genes selected on the basis of relaxed 
criteria, revealed notable differences between these two traits. gF appeared to be 
characterized by genes affecting the quantity and quality of neurons and therefore neuronal 
efficiency, whereas long term depression (LTD) seemed to underlie gC. Thus, this study 
supports the gF-gC distinction at the genetic level and identifies functional annotations and 
pathways worthy of further investigation. 
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INTRODUCTION 
 
A large proportion (40-50%) of inter-individual variability in cognitive abilities is due to 
general intelligence (g), a quantitative trait that reflects the positive correlation among an 
individual’s scores on diverse cognitive ability tests (Deary, 2012; Spearman, 1904). A high g 
score is associated with many favorable life outcomes (Deary & Batty, 2011). Psychometric 
research distinguishes between general fluid intelligence (gF) – the ability to reason in novel 
situations – and general crystallized intelligence (gC) – the ability to apply acquired 
knowledge and learned skills (Carroll, 1993; Cattell, 1963). Although gF and gC are 
correlated at least 50% based on twin studies (Wainwright et al., 2005) and more so early and 
late in life (Li et al., 2004), developmental and cognitive neuroscience studies largely support 
the distinction between them. In normal aging, gF declines earlier and more rapidly than gC 
(Craik & Bialystok, 2006; Salthouse, 2004); in development, measures of verbal (gC) and 
non-verbal (gF) intelligence correlate differently with changes in brain structure (Ramsden et 
al., 2011). Furthermore, gF is closely associated with fronto-parietal and anterior cingulate 
brain networks, while gC is dependent on posterior frontal and temporal regions (Barbey et 
al., 2012; Glascher et al., 2009; Jung & Haier, 2007; Woolgar et al., 2010). Finally, at the 
population level, large gains in performance have been observed for tests that are strongly 
associated with gF, but not with gC (Flynn, 2007). 
 
More than half of the variability in intelligence tests is attributable to additive genetic effects 
(Deary et al., 2009a; Lee et al., 2010; Plomin & Spinath, 2004). In a recent genome-wide 
association study (GWAS), 40% and 51% of the phenotypic variability in gC and gF, 
respectively, could be accounted for by genetic variants in linkage disequilibrium with 
common single nucleotide polymorphisms (SNPs) (Davies et al., 2011), providing a lower-
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bound estimate of the narrow-sense heritability of these traits. Furthermore, using only SNP 
data, ~1% of the variance in intelligence test scores in a sample could be predicted in an 
independent sample (Davies et al., 2011). However, at the single marker level, no robust 
genetic association with intelligence has yet been published, consistent with the observation 
that the effect of individual SNPs may be too weak to be detected in complex polygenic traits 
using the classical genome-wide P≤5x10-8 threshold (Wellcome Trust Case Control 
Consortium, 2007) on the sample sizes currently available (International Schizophrenia 
Consortium, 2009). Therefore, relaxing the significance criteria and exploiting the polygenic 
signal by going beyond the traditional single-marker approach to gene- and pathway-based 
methods may offer more power (Neale & Sham, 2004) and insight into the biological 
processes underlying these traits (Wang et al., 2010). 
 
The polygenic architecture of gF and gC was previously confirmed using the Cognitive Aging 
Genetics in England and Scotland (CAGES) cohort as the discovery sample and the 
Norwegian Cognitive NeuroGenetics (NCNG) adult lifespan sample for replication (Davies et 
al., 2011). Here, using the same datasets, we combine single-marker, gene- and pathway-
based approaches to characterize the genetic architecture of gF and gC with respect to known 
biological processes. 
 
MATERIALS AND METHODS 
 
GWASs: genotypes and phenotypes 
The genotype and phenotype protocols and the samples have been described previously 
(Davies et al., 2011; Espeseth et al., 2012). All participants gave written consent before the 
study started. All procedures were conducted according to the tenets of the Declaration of 
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Helsinki and approved of by the relevant Research Ethics Committees. An overview of the 
genotype and phenotype protocols in the discovery and replication samples is provided below, 
with further details available in the original publications. 
 
Discovery GWAS: The final NCNG GWAS consisted of 554,225 SNPs genotyped in a 
homogenous Norwegian sample of 670 individuals (457 females), ranging from 18 to 79 
years of age (M = 47.6; SD = 18.3) (Espeseth et al., 2012). Participants completed a battery of 
psychometric tests, assessing general cognitive ability, memory, attention and speed of 
processing. The protocol was approved by the Regional Committee for Medical and Health 
Research Ethics, Southern Norway (project ID: S-03116). DNAs were genotyped on the 
Illumina Human610-Quad Beadchip. Quality control was performed with the “check marker” 
function of the R package GenABEL (Aulchenko et al., 2007). Individuals were excluded 
based on relatedness (“ibs.threshold”=0.85), heterogeneity, unresolved sex discrepancies and 
call rate≤0.97. Population structure was assessed by multidimensional scaling (MDS) analysis 
(using 100,000 random SNPs), removing outlying samples with possible recent non-
Norwegian ancestry. No additional adjustment for population structure was performed due to 
the homogeneity of the sample (Espeseth et al., 2012). SNPs with a call rate≤0.95, minor 
allele frequency≤0.01 and Hardy-Weinberg Equilibrium (exact test) P-value≤0.001 were 
excluded. 
 
Replication GWAS: The CAGES sample consists of five cohorts, the Lothian Birth Cohorts of 
1921 (Deary et al., 2009b; Deary et al., 2004) and 1936 (Deary et al., 2007) (LBC1921, 
LBC1936), the Aberdeen Birth Cohort of 1936 (ABC1936) (Deary et al., 2009b; Deary et al., 
2004) and the Manchester and Newcastle Longitudinal Studies of Cognitive Aging cohorts 
(Rabbitt et al., 2004). The final GWAS dataset consisted of 549,692 SNPs genotyped in 3511 
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healthy individuals (2115 females) with detailed cognitive ability measurements taken in 
middle to older adulthood (mean age ranged from 64.6 in the ABC1936 to 79.1 in LBC1921; 
overall age range: 44-93) (Davies et al., 2011). Ethical approval was obtained from the 
relevant Research Ethics Committees. Individuals were excluded based on unresolved gender 
discrepancy, coefficient of relatedness>0.025 (based on 549,692 autosomal SNPs), call 
rate≤0.95 and evidence of non-Caucasian descent as determined by MDS analysis (Davies et 
al., 2011). SNPs were included if they met the following conditions: call rate≥0.98, minor 
allele frequency≥0.01 and Hardy–Weinberg equilibrium test with P≥0.001. Population 
structure was assessed by MDS analysis, and four MDS components were fitted as covariates 
to correct for any population stratification that might be present. 
 
Cognitive phenotypes: Different measures of gF and gC were employed for each of the five 
CAGES samples and the NCNG sample (Davies et al., 2011). In general, the different tests of 
gF aimed to assess each individual’s capacity to reason logically and solve problems in novel 
situations, relatively independently of acquired knowledge. gF employs aspects of processing 
speed, attention, memory and executive function. The gC tests were vocabulary-based, 
assessing each individual’s semantic knowledge. All measures were corrected for sex (with 
the exception of the CAGES Manchester and Newcastle gF, which was derived separately for 
males and females) and age. The standardized residuals were then extracted and used as the 
trait measures in all subsequent analyses. In the NCNG, of the 670 individuals, 629 and 643 
had scores for gF and gC, respectively. In the CAGES, of the 3511 individuals, 3400 and 
3482 had scores for gF and gC, respectively. 
 
Analyses  
Construction of gene lists 
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A ‘bottom-up’ approach (Liu et al., 2007) was undertaken. Both single-marker and gene-
based association analyses were performed, testing SNPs and genes individually first in order 
to construct a list of genes that would then be subjected to pathway analysis, via IPA, to 
identify over-represented functions and/or pathways. For each of gF and gC, genetic factors 
that showed evidence of association in the NCNG were identified and filtered further based 
on evidence of replication in the CAGES. Single-marker and gene-based statistical methods 
and thresholds were selected and applied, as appropriate, with the aim of controlling the Type 
II (false-negative) as well as the inversely related Type I (false-positive) error rates, 
incorporating instead prior biological knowledge to the interpretation of the findings and 
generating testable hypotheses for further investigation (Lieberman & Cunningham, 2009; 
Williams & Haines, 2011). 
 
The LDsnpR tool (Christoforou et al., 2012a) was used to (1) annotate individual SNPs and 
(2) assign SNPs to genes for the gene-based analyses. SNPs were assigned to genes (Ensembl 
54 definitions) if they were located physically within the boundaries of the gene (+/-10kb) or 
if they were in high linkage disequilibrium (LD; r2≥0.80 based on HapMap CEU 
(http://hapmap.ncbi.nlm.nih.gov/)) with another SNP located within the boundaries of the 
gene (+/-10kb). 
 
Single-marker analyses: In the NCNG sample, association between individual SNP alleles 
and cognitive phenotypes was tested using linear regression analysis (1 d.f. coefficient t-test), 
as implemented in PLINK (Purcell et al., 2007). The CAGES GWAS data comprised the 
inverse variance weighted model ‘meta P-values’ produced in the original CAGES five-
sample meta-analysis (i.e. as reported by Davies et al., 2011). A meta-analysis of the CAGES 
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and NCNG single-marker allele P-values was performed on the overlapping SNPs, using an 
inverse variance weighted model, as implemented in METAL (Willer et al., 2010).   
 
All SNPs with an asymptotic nominal P-value ≤0.05 in the NCNG were then mined for 
replication in the CAGES GWAS data. As advised in Konig (2011), positive single-marker 
replication was determined on the basis of P≤0.05 and the same direction of effect in both the 
NCNG and CAGES samples, resulting in a meta-analysis P-value that is more significant than 
either of the original P-values. Using LDsnpR, all SNPs that replicated were annotated, where 
possible, with a gene name or ENSEMBL identifier and taken forward for pathway-based 
analysis by IPA.  
 
Gene-based analyses: All 554,225 SNPs in the NCNG GWAS were assigned, where possible, 
to genes using LDsnpR. For each gene containing a SNP, association was assessed by 
applying PLINK’s permutation-based set test on the LDsnpR-generated sets. Gene-based 
statistics generated by permutation-based methods automatically account for potential 
confounding factors, such as LD structure and gene length or SNP number, through the 
generation of an empirical null distribution (Liu et al., 2010). Since the true underlying 
genetic architecture of these traits is unknown, three different models were tested to obtain a 
gene-based association score (Lehne et al., 2011):  
(1) the minimum P-value (minP) model, which assigns to each gene the association 
statistic, or P-value, of the most significant SNP in the gene, assumes that a single SNP within 
the gene contributes to the phenotype;  
(2) the all P-values model, which assigns to each gene the mean association statistic of 
all the SNPs in the gene, assumes that all or most SNPs within the gene contribute to the 
phenotype;  
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(3) the P<0.05 threshold model, which assigns to each gene the mean association 
statistic of all SNPs within the gene that have a P≤0.05, assumes that only a few or a subset of 
SNP contribute to the phenotype. 
 
The P-values were computed based on 10,000 permutations, and the lowest of the three 
permuted P-values was retained as the gene-based P-value for each gene. No additional 
correction was applied to the gene-based score to account for testing three models due to the 
high correlation between the tests. Genes with gene-based permuted P≤0.05 were mined for 
replication in the CAGES.  
 
In order to preserve the Type II error rate, the replication criteria in the CAGES were relaxed 
to include any gene that contained at least one SNP with a ‘meta-P’≤0.05, ensuring that 
significance under any genetic architecture was captured. In the NCNG, for example, all 
genes with a minimum gene-based permuted P≤0.05 contained at least one SNP with a 
P≤0.05 (data not shown). This replication criterion of at least one SNP with a ‘meta-P’≤0.05 
is equivalent to the unadjusted minimum P-value approach. Thus, the CAGES SNPs were first 
assigned to genes using LDsnpR, as described above, and the genes were scored using the 
minimum P-value approach, assigning to the gene the P-value of the most significant SNP in 
that gene (without further adjustment). All genes that were selected from the NCNG and that 
also replicated in the CAGES (i.e. meta-P≤0.05) were taken forward for analysis with IPA. 
Finally, after the relevant gene lists were pruned for LD on the basis of their association 
signals and position, the hypergeometric distribution, as implemented in 
www.geneprof.org/GeneProf/tools/hypergeometric.jsp, was used to assess whether the 
number of genes replicating in the CAGES was greater than expected by chance. 
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Construction of gene lists – stringent replication criteria: Since the aforementioned single-
marker and gene-based replication criteria in the CAGES are prone to inflating the Type I 
error rate due to gene-length bias, the robustness of the subsequent main IPA findings was 
assessed by re-running IPA on gene lists constructed using more stringent statistical 
thresholds and methods. Firstly, for the single-marker analysis, only genes tagged by the 
SNPs that met the previously described replication criteria and resulted in a meta-analysis 
P≤1x10-5, as supported by the National Human Genome Research Institute GWAS catalog 
(Welter et al., 2014), were taken forward for IPA analysis. For the gene-based analysis, 
replication in the CAGES was determined using two gene-scoring methods which accounted 
for the number of SNPs per gene and, critically, for LD without requiring genotype-level data. 
The first method scored each gene with the most significant P-value (i.e. the minP approach), 
adjusting for the number of SNPs using a modified Sidak’s correction (Saccone et al., 2007). 
This approach has been shown to perform as well as regression-based methods (Segre et al., 
2010; Christoforou et al., 2012a). The second approach was comparable to the regression-
based ‘all P-values’ model described above, combining all SNPs mapped to the gene using 
Brown’s approximation method, as implemented in PLINK (Moskvina et al., 2011; Purcell et 
al., 2007). The NCNG genotype data was used to estimate the LD between SNPs. Thus, the 
genes with gene-based permuted P≤0.05 in the NCNG which met a P≤0.05 with either of 
these two methods in the CAGES were subjected to IPA analysis. 
 
Ingenuity Pathway Analysis (IPA) 
Genes that showed evidence of association in the NCNG and of replication in the CAGES 
based on either the single-marker and/or the gene-based analysis were selected for pathway 
analysis with IPA (Ingenuity® Systems, www.ingenuity.com) to identify the most relevant 
biological functions and pathways. IPA gathers information from published data from ~3600 
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peer-reviewed journals regarding relationships between genes and proteins. The information 
is updated weekly, manually curated and stored within the Ingenuity® Knowledge Base, 
which is then queried during an analysis to identify specific biological functions, or “function 
annotations”, and pathways enriched within the submitted gene list. 
 
In this study, the Ensembl 54 gene identifiers were uploaded into IPA and mapped, if 
possible, to their corresponding object in the Ingenuity® Knowledge Base (Genes Only). A 
“Core Analysis” was performed, including both direct and indirect relationships and using all 
available data sources in all species available. Molecules and/or relationships that were either 
experimentally observed or predicted with high confidence were considered. For the main 
analyses, which aimed to differentiate gF and gC as it relates, most relevantly, to the nervous 
system, tissues and primary cells were restricted to those of the nervous system and cell lines 
were restricted to those of the central nervous system. Additional analyses were performed to 
evaluate the robustness and relevance of the main findings, including (1) re-running the IPA 
having excluded genes known to be extensively studied to assess the possibility of publication 
bias driving the main findings and (2) re-running the IPA having included all tissues and cell 
lines, except those specific to cancer, to assess the relevance of the main findings in the 
context of more global annotation. 
 
In particular, we focused on the significant function annotations. The function annotations are 
organized based on Ingenuity® Ontology, which consists of a manually built and maintained 
hierarchical data structure of hundreds of thousands of unique classes. As part of the ‘Core 
Analysis’, IPA performs a Fisher Exact Test (FET) to determine whether the submitted gene 
list consists of genes of a particular function annotation more than expected by chance given 
the proportion of genes of that particular function annotation in the entire Ingenuity 
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Knowledge Base. It also uses the Benjamini-Hochberg (BH) multiple testing correction 
method to adjust for the number of ontologies tested, providing a false discovery rate for a 
particular function annotation. In this study, all functional annotations with a FET P<0.05 
(and corresponding BH P<0.25) were considered significant. 
 
RESULTS 
Construction of gene lists 
Single-marker analyses: A total of 554,225 SNPs were tested for allelic association to gF 
(N=629 individuals) and gC (N=643 individuals) in the NCNG sample. As these GWAS data 
results were not presented in the previous study (Davies et al., 2011), the traditional SNP-
level diagnostics and results are provided in the Supporting Information (Figure S1 and 
Dataset S1). The genomic inflation factor was 1 for both gF and gC (Figure S1), indicating 
that the data did not suffer from population stratification or other systematic bias. When 
mining the CAGES data, 816 SNPs in gF and 884 SNPs in gC met the replication criteria of 
P≤0.05 and the same direction of effect (Supporting Information Dataset S1). Using the LD-
based binning approach implemented in LDsnpR (Christoforou et al., 2012a), 481 (59%) of 
the gF SNPs and 549 (62%) of the gC SNPs were assigned to Ensembl 54 genes. 159 gF 
SNPs and 160 gC SNPs mapped to more than one gene on the basis of LD. Since it is not 
possible to identify the true source of the association on the basis of the SNP P-value alone 
(Christoforou et al., 2012a,b), all genes were retained for pathway analysis. The significant 
function annotations or pathways were subsequently manually examined to ensure that they 
did not consist of clusters of genes representing the same genetic association signal. Thus, 503 
and 530 Ensembl 54 genes for gF and gC, respectively, (Supporting Information Dataset S1) 
were taken forward for IPA analysis. 171 (34%) of the gF genes and 212 (40%) of the gC 
genes were implicated by more than one replicated SNP. 
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Gene-based analyses: A gene-based approach was also used to identify candidate genes for 
pathway analysis, allowing for locus heterogeneity and the aggregation of multiple weaker 
association signals. In the NCNG, of the 34,109 eligible Ensembl 54 gene entries, 2698 and 
2615 met the nominal significance threshold of set-based permuted P≤0.05 in gF and gC, 
respectively (Supporting Information Dataset S2). Of these, 841 gF genes and 920 gC genes 
had a minimum P-value gene-based score of P≤0.05 in the CAGES (Supporting Information 
Dataset S2). After the relevant gene lists were first pruned for LD based on position and 
association signal, resulting in 607 and 652 relatively independent association signals for gF 
and gC, respectively, the number of genes showing evidence of replication was more than 
expected by chance for gC (hypergeometric P=4.5x10-4), but not for gF (hypergeometric 
P=0.25). The 841 gF genes and 920 gC genes were added to the list of genes identified by 
single-marker analysis and taken forward for IPA.  
 
Ingenuity Pathway Analysis 
Figure 1 summarizes the number of SNPs and genes identified in each analysis and the 
relevant corresponding overlaps. 1182 genes for gF and 1294 genes for gC were identified 
through both the single-marker and gene-based analyses and subjected to IPA analysis. Of 
these genes, 853 for gF and 893 for gC were identified by their Ensembl Gene identifier in the 
IPA database (i.e. “IPA Ready” genes; Supporting Information Dataset S3) and were thus 
available for pathway analysis. 117 genes were in common between the two traits.  
 
IPA’s “Core Analysis” was run on the two lists of genes, restricting the analysis to tissues and 
cell lines related to the nervous system. Function annotations that were significantly enriched 
with a Fisher Exact Test (FET) P<0.05 and a Benjamini-Hochberg (BH) P<0.25, which 
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account for all of the function annotations tested, were declared significant and evaluated. For 
both traits, function annotations involved in the biological function “Nervous System 
Development and Function” were the most common, accounting for >25% of the function 
annotations. These were followed by annotations involved in “Cell-to-Cell signaling” and 
“Cellular Assembly and Organization” in both gF and gC (~8%) (Supporting Information 
Dataset S3). However, it is important to note that some function annotations are categorized 
under multiple biological functions, resulting in redundancy in the data (e.g., “axonogenesis” 
appears under “Nervous System Development and Function”, “Cell Morphology”, “Cellular 
Function and Maintenance”, “Cellular Assembly and Organization” and “Tissue 
Development”). When considering only the non-redundant function annotations, specifically 
those identified on the basis of at least two genes from the inputted gene list, 85 and 54 
function annotations were identified as significantly enriched in gF and gC, respectively 
(Supporting Information Dataset S3). 
 
Only four function annotations were enriched in both gF and gC, including “microtubule 
dynamics” and “chemotaxis of neurons”, which could be generally categorized as 
architectural features of neuronal development. The set of genes leading to the enrichment of 
these overlapping annotations in gF was different to that in gC (Table 1), except for the 
“migration of GABAergic neurons” annotation which was attributed to the same two genes in 
gF and gC. 
 
The most statistically significant functional annotations were identified in gC. “Synaptic 
depression” ranked at the top (FET P=2.9x10-6; BH P=0.0015), with the related “long term 
depression” in general (LTD; FET P=2.0x10-5; BH P=0.0052) and LTD of specific cells 
(Table 2), all of which are highly related as indicated by the composite genes. “Guidance of 
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axons” and “schizophrenia” were also significantly enriched in gC (FET P=4.8x10-4 and 
0.042, respectively), the former also ranking third (Table 2 and Supporting Information 
Dataset S3). 
 
The general functional enrichment profiles of gF and gC were different. No function emerged 
as notably significant in gF, a finding which was further emphasized by the ‘flat’ multiple-
testing corrected BH P-value of 0.18 for all significant annotations. The most significantly 
enriched functional annotation identified was “synaptic fatigue of synapse” (FET P=0.0021), 
followed by “apoptosis of spinal cord cells” (FET P=0.0041) and “inhibition of neurons” 
(FET P=0.0053) (Table 3). However, the predominance of function annotations relating to 
“quantity”, particularly of neurons and of other structures of the nervous system was notable 
(Table 3, Supporting Information Figure S2 and Dataset S3). Other functions were related to 
the quantity (e.g., formation, loss, survival, and apoptosis), quality (e.g. synaptic fatigue, 
degradation, atrophy and myelination), or morphology of neurons or related structures. Long-
term potentiation (LTP) was another repeated function for gF (Supporting Information Figure 
S2). One gene, brain-derived neurotrophic factor (BDNF), which showed gene-based 
association with gF (Supporting Information Dataset S2), contributed to the enrichment of 
several significant function annotations for gF (Table 3 and Supporting Information Dataset 
S3). As BDNF is one of the most extensively studied genes in the field (Green et al., 2008), it 
could bias the IPA results, which are based on peer-reviewed publications. However, when 
IPA was run without BDNF, most of the significant findings withstood its exclusion (Table 3 
and Supporting Information Dataset S3) and the general functional enrichment profile 
observed in gF was preserved. A manual examination of the chromosomal positions of the 
sets of genes leading to the enrichment of the significant annotations listed in Tables 1-3 
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ensured that these significant enrichments are due to independent association signals and not 
to clusters of genes in LD representing the same association signal. 
 
In order to gauge the robustness of the above findings in the absence of the gene-length bias 
that may have been introduced with the relaxed replication criteria, the CNS-specific IPA 
analysis was also performed on gene lists constructed on the basis of more stringent 
replication criteria. For gF, the single-marker analysis identified two genes which contained 
replicated SNPs that met the meta-analysis P≤1x10-5 threshold (Supporting Information 
Dataset S1). The gene-based analysis identified 178 genes with gene-based P≤0.05 using 
either the modified Sidak approach or Brown’s approximation method (Supporting 
Information Dataset S2). Together, this resulted in a total of 180 genes available for IPA 
analysis for gF. For gC, 5 and 224 genes were identified via the single-marker and gene-based 
analyses, respectively, resulting in 225 unique genes available for IPA analysis. Nine genes 
were common to both gF and gC. 
 
The IPA results emerging from the abridged gene lists were not as impressive in terms of the 
number of significant unique function annotations (N=26 and 8 for gF and gC, respectively) 
and in terms of their general enrichment profiles for gF and gC (Supporting Information 
Dataset 3). Also, for both traits, different function annotations emerged as most significant, 
namely “neuritogenesis” for gF (FET P=2.8x10-4) and “hypoplasia of cerebellar vermis” (FET 
P=0.0015) (Supporting Information Dataset 3). However, the main functions which were 
found to distinguish gF from gC in the original, less conservative analysis remained 
significant. “LTD” and “synaptic depression” remained unique to gC albeit at a reduced 
significance level (FET P=0.018 and 0.047, respectively) (Table 2 and Supporting 
Information Dataset 3). For gF, functions which related to quantity, quality or morphology of 
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neurons and synapses still predominated. These included “quantity”, “morphogenesis” and 
“development” of neurons, synapses and other brain structures (Supporting Information 
Dataset 3). No function annotations were common to both traits in this analysis. 
 
Finally, returning to the original gene lists based on the relaxed criteria, IPA was run again on 
both traits, using information from all cell lines, with the exception of cancer cell lines, in the 
Ingenuity® Knowledge Base. This helped to evaluate the primary CNS-restricted results 
relative to more global annotation, to identify annotations that may be related to cognitive 
ability and to enable the inclusion of published studies of brain-related traits that were 
executed in non-CNS cell lines, such as lymphoblastoid cell lines (Gladkevich et al., 2004). 
The significance of the original, CNS-restricted findings was largely unaffected. The most 
significant annotations for gF in this analysis fell under the Disease and Disorder Category of 
Cardiovascular Disease (e.g. “vascular disease”, FET P=7.1x10-6; Supporting Information 
Dataset S3). In addition, the function annotations “development of brain”, “behavior”, 
“cognition disorders”, “cognitive impairment” and “schizophrenia” were also significantly 
enriched in gF (Supporting Information Dataset S3). For gC, “synaptic depression” remained 
the most significant annotation. However, it was followed by the Cardiovascular Disease 
function annotation “coronary artery disease” (FET P=1.8x10-6; Supporting Information 
Dataset S3). The significance of the enrichment of “schizophrenia” also marginally improved 
(from FET P=0.042 to FET P=0.026, Supporting Information Dataset S3). 
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DISCUSSION  
Novel polygenic approaches to analysing GWAS data have greatly improved our 
understanding of complex traits and have captured more of the “hidden heritability” (Davies 
et al., 2011; Visscher et al., 2012; Maher, 2008; Manolio et al., 2009) but have failed to 
identify the markers or genes implicated. Pathway-based techniques are complementary 
polygenic methods that support biological analysis of GWAS data. Gene-based methods, 
which are ideal for pathway-based approaches (Liu et al., 2010), permit the aggregation of 
SNPs of smaller effect and test the gene as a whole, potentially increasing power (Neale & 
Sham, 2004). These analyses are also more permissive to locus heterogeneity, where multiple 
independent variants within a locus have independent effects on a trait (Christoforou et al., 
2012a; Yang et al., 2012), and they use prior biological knowledge, facilitating a more 
meaningful interpretation of data (Wang et al., 2010). Therefore, if the genetic signals 
underlying gF and gC, two highly heritable and polygenic traits, cluster in known biological 
pathways, it should be possible to use pathway-based analyses to identify which biological 
processes are most strongly implicated in these subcomponents of g. We particularly wanted 
to determine whether gF and gC could be differentiated at the level of biological pathways or 
functions as they have been shown to be distinct in terms of development and brain structure. 
Taking a ‘bottom-up’ approach (Liu et al., 2007), we analysed two GWAS datasets using both 
single-marker and gene-based analyses to construct gene lists for IPA analysis. Although 
some significantly enriched functions overlapped in the two traits, the overall picture 
suggested distinct functional enrichment profiles, supporting the gF-gC distinction at the 
genetic level. 
 
The most statistically significant finding was the enrichment in gC of genes involved in 
synaptic depression and LTD. This finding, which was unique to gC, also survived the FDR 
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multiple testing correction at the more conservative 0.05 threshold and the application of 
more stringent replication criteria for the construction of gene lists. It was also the top finding 
when the pathway analysis included non-CNS-related tissue types and conditions. LTD and 
long-term potentiation are the major forms of long-lasting synaptic change in the mammalian 
brain (Collingridge et al., 2010). LTD is involved in synaptic pruning during development 
(Peineau et al., 2007) and is thus important in adult neuroplasticity. Synaptic LTD is mediated 
by the effect of L-glutamate and other neurotransmitters on several types of receptors. The 
resulting synaptic plasticity is necessary for hippocampus-dependent learning and memory, 
certain types of behavioral flexibility and novelty detection (Collingridge et al., 2010). LTD 
deficits have been associated with reduced working memory and reversal of memory 
performance in rats. Studies focusing on medial temporal lobe regions have revealed a role of 
LTD in memory stabilization (in the amygdala) (Migues et al., 2010) and recognition memory 
(in the perirhinal cortex) (Winters & Bussey, 2005), implicating LTD in the development and 
maintenance of knowledge representations. 
 
For gF, the association signal was less striking in terms of statistical significance. gF was 
predominantly characterized by genes that control the quantity, morphology and integrity of 
neurons and synapses. These factors affect the quality and efficiency of neuronal signaling 
(Brown et al., 2008), which, in turn, affect cognition, as indicated by reduced activation in 
individuals with higher cognitive ability (Prat et al., 2007; Reichle et al., 2000). Since gF 
declines in cognitive ageing, the enrichment of these functions is consistent with the decline 
in synapse number, brain volume, and white matter integrity in the ageing brain (Fjell et al., 
2009; Morrison & Hof, 1997; Walhovd et al., 2011; Westlye et al., 2010). 
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Only four function annotations were common to both traits. These were related to 
development and structural aspects (e.g., microtubule dynamics, dendrite formation), which 
play central roles in synapse formation and are thus likely to be important for cognitive 
function (Bramham et al., 2010). The genes leading to enrichment of three of these functions 
were different for gF and gC, reflecting the gain of information that gene-set or pathway-
based approaches offer by enabling the identification of overlap between related traits or 
replication of the same trait. 
 
The function annotation “schizophrenia” was also significantly enriched in gF and gC, 
indicating that the identified genes have also been implicated in schizophrenia by other 
studies. A polygenic risk score for schizophrenia was recently shown to be associated with 
lower IQ at age 70 and greater decline in IQ level in one of the CAGES cohorts (Mcintosh et 
al., 2013), confirming previous observations at the single candidate level of a genetic relation 
between general cognition and schizophrenia (Toulopoulou et al., 2010). Furthermore, 
enrichment of the terms “behavior”, “cognition disorders” and “cognitive impairment” 
suggests that the genes identified here have been implicated in other studies of cognition. 
Finally, annotations relating to “cardiovascular disease” ranked in the top two in both gF and 
gC. Cognitive dysfunction is well documented in patients with cardiovascular disease (Vogels 
et al., 2007). 
 
The heritability for gF and gC are similar, but the strength of association, extent of replication 
and strength of enrichment were all greater for gC than for gF (Davies et al., 2011). There are 
several possible reasons for this. First, gF may be more heterogeneous at the phenotype level. 
While gC was defined as the standardized score of a single measure in each sample, gF 
estimation was based on a hierarchical principal component analysis from an array of specific 
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measures. The idea that the psychometric structure of gF is more heterogeneous is consistent 
with another major model of intelligence (Johnson & Bouchard, 2005; Vernon, 1964), in 
which verbal abilities are retained as a single second stratum component, while fluid abilities 
are separated into perceptual and mental rotation skills, thus reflecting higher phenotypic 
complexity. Second, assessment of gF was not based on identical subsets of specific tests in 
NCNG and each of the CAGES subsamples. However, the different batteries of cognitive 
tests yield almost identical estimates of general intelligence (Johnson et al., 2004). Third, the 
age differences between the samples could have a differential effect given that gF decreases 
with age while gC is relatively stable, even though the correlation between them increases 
with age (Li et al., 2004). Finally, the difference in enrichment profiles may be magnified by 
gene-length bias, given that a stronger association was identified for gF when IPA was re-run 
using the genes that passed the more stringent criteria. 
 
The main complicating factor in this and other studies of brain-related traits is gene-length 
bias, as it presents an analytical ‘Catch-22’.While it is important to correct genes for their 
length, or equivalently, the number of SNPs tested, to control for false findings, doing so risks 
over-penalizing and thus eliminating the most relevant candidate genes and therefore 
pathways for intelligence. It is recognized that gene length is related to functional complexity 
(Xu et al., 2006) and it is known that brain-expressed genes involved in relevant neuronal 
processes and/or associated with autism and intellectual disability are substantially longer 
(King et al., 2013; Michaelson et al., 2012). Also, it has been suggested that longer genes are 
larger targets and therefore more prone to random mutation and are subject to different 
transcriptional mechanisms that may be functionally relevant to brain-related traits (King et 
al., 2013; Solier et al., 2013). Thus, in order to balance the competing Type I and II error 
rates, we focused our analysis on a well-accepted and recommended discovery-replication 
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approach (Jia et al., 2011), running the replication in one of the largest samples of its kind 
(the CAGES). Strict replication criteria were used in the single-marker analyses (Konig, 
2011). For the gene-based analyses, a robust permutation-based approach, which accounts for 
LD structure and SNP number, was used to select genes for replication, the criteria for which 
were subsequently relaxed to avoid over-penalizing the larger, more relevant genes. In order 
to then assess the robustness of these findings, IPA was also run on genes that survived the 
more stringent approach which corrects for SNP number. Since the power of the IPA analysis 
was greatly compromised by the ~6-fold reduction in the number of genes available for the 
analysis, it was not surprising that the evidence for the genetic distinctiveness of the two traits 
was weaker. Nevertheless, the main distinguishing features between gF and gC were upheld. 
This suggests that the true genetic architecture of these two traits may lie in the middle, and is 
inaccessible using current approaches which either ignore or over-penalize for the length of 
the gene.  
 
As larger consortia form and pathway analyses continue to improve, a better understanding of 
the genetic architecture of gF and gC will emerge (Lencz et al, 2014; Khatri et al., 2012). 
Meanwhile, our study serves as a starting point, supporting the gF-gC distinction at the 
genetic level and critically converging with the findings of developmental and cognitive 
neuroscience studies. The specific function annotations, or pathways, identified are worthy of 
further replication and interrogation, using, for example, ‘top-down’ approaches such as gene 
set enrichment analysis (Fernandes et al., 2013) to test specific gene sets constructed on the 
basis of these findings.  
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FIGURE LEGEND 
 
Figure 1. Summary of SNP- and gene-based analyses and corresponding numbers of 
genes identified for IPA for both gF (left) and gC (right). The boxed numbers in the centre 
represent the number of genes identified as a result of the SNP-based analyses (from top, 
down), the gene-based analyses (from bottom, up), the resulting total number of unique genes 
submitted to IPA and the number of relevant overlapping genes (in parentheses). * indicates 
that the GWAS SNPs were assigned to genes by LDsnpR. 
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Table 1. Significant IPA Function Annotations in both gF (left) and gC (right). 
 
 
  gF   gC   
Function Function 
Annotation (FA) 
FET P-
value 
BH P-
value 
Genes FET P-
value 
BH P-
value 
Genes
chemotaxis chemotaxis of 
neurons 
0.025 0.18 BDNF, GFRA1, RGS3 0.0037 0.17 EPHB2, GFRA1, SEMA3A, SLIT2
formation formation of 
dendrites 
0.028 0.18 ACHE, BCL11A, BDNF, CTNNA2, GRIN3A, 
NRG1, PRKG1, SGK1, SYNE1 
0.035 0.22 DAB1, DSCAM, KLF7, KNDC1, MAP2, 
NRG1, PPP1R9B, RAC2, SEMA3A 
organization microtubule 
dynamics 
0.030 0.18 ACHE, ATXN10, BAX, BCL11A, BCL2, BDNF, 
BSN, CDH1, CNTN4, CNTNAP2, CTNNA2, 
CTNND2, CYP19A1, DISC1, EGFR, GDA, 
GRIN3A, GSN, IGF1R, KATNB1, MAPK8, 
NFIB, NRG1, PRKG1, PTPRM, RND1, SGK1, 
SLC18A3, SLIT1, SLIT3, SNCA, SYNE1, 
UHMK1 
0.032 0.22 ATXN2, BBS10, CDH4, CNTN4, DAB1, 
DCC, DSCAM, EPHB1, EPHB2, GPM6A, 
KLF7, KNDC1, LAMB1, LRRC7, MAP2, 
MBP, MTOR, NRG1, PCDH15, PLD1, 
POU3F1, PPP1R9B, PRICKLE2, PRKCA, 
PTPRM, RAC2, RIT2, RUFY3, SEMA3A, 
SLIT1, SLIT2, TNFRSF12A, TRPV4, VANG 
migration migration of 
GABAergic neurons 
0.012 0.18 GFRA1, SLIT1 0.013 0.22 GFRA1, SLIT1
 
For each general function, the specific function annotation (FA) is shown together with the corresponding Fisher Exact Test (FET) P-value, the 
Benjamini-Hochberg (BH) multiple testing corrected P-value and the genes responsible for the enrichment signal in the function annotation. 
Individual genes that contribute to the enrichment of a particular FA in both gF and gC are in bold. 
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Table 2. Top 25 IPA Function Annotations for gC 
  
Function Function Annotation (FA) FET P-value BH P-value # Genes Genes
synaptic 
depression 
synaptic depression 2.9x10-6 0.0015 13 ADCY5, ADCY8, CNR1, DRD5, EPHB1, EPHB2, GRM7, LRRC7, MTOR, PRKCA, RYR3, ST8SIA4, SYNJ1, (ITSN1)
long term 
depression 
long term depression 2.0x10-5 0.0052 11 ADCY5, ADCY8, CNR1, DRD5, EPHB2, GRM7, LRRC7, MTOR, PRKCA, RYR3, ST8SIA4
guidance guidance of axons 4.8x10-4 0.061 16 ALCAM, ANK3, CDH4, CNTN4, DCC, EPHB1, EPHB2, ERBB4, EXT1, GLI3, KLF7, NFASC, PLXNA2, SEMA3A, 
SLIT1, SLIT2 
long term 
depression 
long term depression of cells 4.8x10-4 0.061 6 ADCY5, CNR1, DRD5, PRKCA, RYR3, ST8SIA4
long term 
depression 
long term depression of brain 
cells 
7.2x10-4 0.075 5 ADCY5, CNR1, PRKCA, RYR3, ST8SIA4
long term 
depression 
long term depression of 
neurons 
0.0013 0.11 5 ADCY5, CNR1, DRD5, RYR3, ST8SIA4
assembly assembly of olfactory cilia 0.0020 0.13 3 BBS10, PCDH15, VANGL2 
long term 
depression 
long term depression of 
corticostriatal neurons 
0.0023 0.13 2 ADCY5, CNR1
positioning positioning of cholinergic 
neurons 
0.0023 0.13 2 SLIT1, SLIT2
contact repulsion contact repulsion 0.0034 0.17 3 DCC, SEMA3A, SLIT2
chemotaxis chemotaxis of neurons 0.0037 0.17 4 EPHB2, GFRA1, SEMA3A, SLIT2 
development development of optic chiasm 0.0068 0.22 2 SLIT1, SLIT2
size size of lateral cerebral ventricle 0.0068 0.22 2 ANK2, NRG1 (includes EG:112400) 
apoptosis apoptosis of sensory neurons 0.0076 0.22 3 CDKN2D, HIPK2, KLF7
metabolism fatty acid metabolism 0.010 0.22 5 DAB1, ERBB4, NRG1, SEMA3A, ST8SIA1
abnormal 
morphology 
abnormal morphology of 
nervous system 
0.013 0.22 2 CNR1, UHRF1
formation formation of oligodendrocytes 0.013 0.22 2 ERBB4, NRG1 
guidance guidance of thalamocortical 
axons 
0.013 0.22 2 SLIT1, SLIT2
migration migration of GABAergic 
neurons 
0.013 0.22 2 GFRA1, SLIT1
pathfinding pathfinding of axons 0.013 0.22 2 DCC, EXT1
chemotaxis chemotaxis of cells 0.014 0.22 5 EPHB2, FPR2, GFRA1, SEMA3A, SLIT2
development development of diencephalon 0.014 0.22 3 SIM2, SLIT1, SLIT2
long term 
depression 
long term depression of 
synapse 
0.018 0.22 3 CNR1, GRM7, MTOR
synthesis synthesis of fatty acid 0.020 0.22 4 DAB1, ERBB4, NRG1, SEMA3A 
synthesis synthesis of lipid 0.020 0.22 6 CNR1, DAB1, ERBB4, NRG1, SEMA3A, ST8SIA1
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Table 2. Top 25 IPA Function Annotations for gC. For each general function, the specific function annotation (FA) is shown together with its 
corresponding Fisher Exact Test (FET) P-value, the Benjamini-Hochberg (BH) multiple testing corrected P-value, the number of genes and the 
symbols of the genes responsible for the enrichment signal in the FA. The functions and FAs that remained significant in the IPA analysis of the 
genes that passed the more stringent criteria are underlined. The gene(s) in parentheses are those that emerged from the more conservative 
analysis. 
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Table 3. Top 25 IPA Function Annotations for gF. 
 
Function Function Annotation (FA) FET P-
value 
BH P-
value 
# 
Genes 
Genes 
synaptic fatigue synaptic fatigue of synapse 0.0021 0.18 2 BDNF, SYN3 
apoptosis apoptosis of spinal cord cells 0.0041 0.18 4 BAX, BCL2, BDNF, FAM134B 
inhibition inhibition of neurons 0.0053 0.18 4 BDNF, NPPA, NPPB, NRG1  
development development of sensory nervous 
system 
0.0062 0.18 2 BDNF, KIF1A 
inhibition inhibition of pyramidal neurons 0.0062 0.18 2 BDNF, NRG1  
concentration concentration of arachidonic 
acid 
0.0062 0.18 2 DGKE, KNG1
endocytosis endocytosis of synaptic vesicles 0.0067 0.18 4 AMPH, CABIN1, ITSN1, SNCA
damage damage of cortical neurons 0.0067 0.18 3 BAX, BDNF, GRIN3A 
quantity quantity of central nervous 
system cells 
0.0090 0.18 9 ACHE, AVPR1B, CCND2, EGFR, GDA, IGFBP6, LEF1, LHX5, TSC1 
long-term 
potentiation 
long-term potentiation 0.0092 0.18 13 B3GAT1, BDNF, CDH1, CHRNA7, CYP19A1, DGKE, LRP1, LRP8, NRG1, PLG, SNCA, VAV2, 
VAV3 
apoptosis apoptosis of dorsal root ganglion 
cells 
0.0093 0.18 3 BAX, BCL2, FAM134B 
mobilization mobilization of Ca2+ 0.0093 0.18 3 BDNF, PROK2, TRPV1 
morphogenesis morphogenesis of neurites 0.0097 0.18 22 ACHE, ATXN10, BDNF, BSN, CNTN4, CNTNAP2, CTNNA2, CTNND2, CYP19A1, EGFR, GDA, 
IGF1R, MAPK8, NRG1, PRKG1, PTPRM, RND1, SGK1, SLC18A3, SLIT1, SYNE1, UHMK1, 
(TLR7) 
growth growth of dendrites 0.0099 0.18 5 BDNF, CTNND2, CYP19A1, NRG1, SLIT1 
morphology morphology of dendrites 0.0099 0.18 5 BDNF, DISC1, GRIN2D, NPAS3, NRG1 
quantity quantity of acetylcholine 0.012 0.18 2 ACHE, SLC18A3 
survival survival of dorsal root ganglion 0.012 0.18 2 BAX, BDNF 
synaptogenesis synaptogenesis of brain cells 0.012 0.18 2 BDNF, CYP19A1
long-term 
potentiation 
long-term potentiation of granule 
cells 
0.012 0.18 2 BDNF, DGKE
sensitization sensitization of neurons 0.012 0.18 2 BDNF, KNG1 
migration migration of GABAergic neurons 0.012 0.18 2 GFRA1, SLIT1 
quantity quantity of astrocytes 0.012 0.18 4 ACHE, EGFR, IGFBP6, TSC1 
cell viability cell viability of motor neurons 0.015 0.18 5 BAX, BCL2, BDNF, GFRA1, REG3G 
loss loss of motor neurons 0.016 0.18 3 BCL2, BDNF, GFRA1 
quantity quantity of nerve ending 0.016 0.18 3 BDNF, SLC18A3, SNCA 
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Table 3. Top 25 IPA Function Annotations for gF. For each general function, the specific function annotation (FA) is shown together with the 
corresponding Fisher Exact Test (FET) P-value, the Benjamini-Hochberg (BH) multiple testing corrected P-value, the number of genes and the 
symbols of the genes responsible for the enrichment signal in the function annotation. FAs that remained significant after excluding BDNF are in 
bold. The functions and FAs that remained significant in the IPA analysis of the genes that passed the more stringent criteria are underlined. The 
gene(s) in parentheses are those that emerged from the more conservative analysis. 
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